Viewing Study NCT04640402


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-01-29 @ 1:21 AM
Study NCT ID: NCT04640402
Status: COMPLETED
Last Update Posted: 2022-06-01
First Post: 2020-11-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)
Sponsor: Jiangsu Province Centers for Disease Control and Prevention
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Safety View
None Immunogenicity View
None COVID-19 Vaccine View
None Recombinant vaccine View